BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
- Conditions
- Breast Cancer
- Interventions
- Registration Number
- NCT00625898
- Lead Sponsor
- NSABP Foundation Inc
- Brief Summary
The trial will determine the value of adding bevacizumab to chemotherapy plus trastuzumab in patients with resected node-positive or high risk node-negative, HER2-positive breast cancer.
- Detailed Description
This Phase III, randomized, open-label trial will determine whether the regimens of chemotherapy plus trastuzumab plus bevacizumab improve invasive disease-free survival (IDFS) relative to the regimens of chemotherapy plus trastuzumab. Secondary aims include determining whether the addition of bevacizumab to chemotherapy plus trastuzumab will improve disease-free survival (DFS), overall survival (OS), recurrence-free interval (RFI), and distant recurrence-free interval (DRFI). The benefit of adding bevacizumab for IDFS, DFS, OS, RFI, and DRFI will also be evaluated for each of the two chemotherapy regimens. The cardiac and non-cardiac toxicities of each of the regimens will also be evaluated.
Following local determination that the tumor is HER2-positive for gene amplification by in situ hybridization or is IHC 2+ or 3+, a tumor sample must be submitted for HER2 testing by a designated central laboratory. If central testing confirms that the tumor is HER2-positive (either positive by FISH or IHC 3+) and all other eligibility criteria have been met, the patient will be randomized to a regimen of chemotherapy and trastuzumab with or without bevacizumab.
Patients in the trial will be enrolled in one of two chemotherapy regimen cohorts. One cohort will receive 6 cycles of docetaxel/carboplatin plus trastuzumab (TCH) with or without bevacizumab; the other cohort will receive 3 cycles of docetaxel plus trastuzumab given with or without bevacizumab followed by 3 cycles of 5-Fluorouracil, Epirubicin, Cyclophosphamide (TH-FEC). With both regimens, patients will continue trastuzumab with or without bevacizumab following chemotherapy to complete 1 year of targeted therapy. Following completion of chemotherapy, patients will also receive adjuvant radiotherapy and endocrine therapy as clinically indicated.
The trial will be conducted by investigators affiliated with the Cancer International Research Group (CIRG) and the National Surgical Adjuvant Breast and Bowel Project (NSABP). CIRG and NSABP investigators will only enroll patients in the TCH regimen cohort. Additional investigators, referred to in the protocol as Independent Investigators, will enroll patients in both the TCH regimen or the TH-FEC regimen cohort depending on institutional preference for the one regimen that will be used by that institution for the duration of the trial.
Patients will be given the option of allowing their tumor samples to be used for the BETH translational research and correlative science studies. Also, patients will be asked to consent to the submission of blood and serum samples at scheduled time points during the study.
LVEF assessments will be performed before study entry and then at scheduled time points during therapy and at 18, 36, and 60 months following randomization.
The planned sample size for the trial is 3,000 patients randomized in the faster accruing cohort and a minimum of 3,500 patients overall.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 3509
- Life expectancy of at least 10 years, excluding their diagnosis of breast cancer.
- Women who have had breast reconstruction utilizing tissue expanders must be in agreement with delaying surgery to replace the tissue expanders with permanent implants until 3 months following the last dose of bevacizumab
- Women of reproductive potential must agree to use an effective non-hormonal method of contraception (for example condoms, some intrauterine devices, diaphragms, vasectomized partner, or abstinence) during therapy and for at least 6 months after the last dose of bevacizumab and/or trastuzumab.
- Submission of tumor samples from the breast surgery for central HER2 testing is required for all patients prior to enrollment in the BETH Trial
- Signed and dated IRB/EC-approved consent
- ECOG performance status of 0 or 1
- The tumor must be unilateral invasive adenocarcinoma of the breast on histologic examination.
- The breast cancer must be HER2-positive based on test results as follows: Local testing (if available) should demonstrate that the tumor is IHC 2+ or 3+ or is considered to be HER2-positive for gene amplification by FISH, CISH, or other in situ hybridization (ISH) method. If local ISH test results are considered equivocal, the tumor can be submitted for central HER2 testing. (If local testing is not possible, the tumor can be submitted for central HER2 testing.) Central testing (a requirement for ALL patients) must demonstrate that the tumor is HER2-positive which is defined as FISH-positive and/or IHC 3+.
- All of the following staging criteria (according to the 6th edition of the AJCC Cancer Staging Manual) must be met: By pathologic evaluation, primary tumor must be pT1-3; By pathologic evaluation, ipsilateral nodes must be pN0, pN1 (pN1mi, pN1a, pN1b, pN1c), pN2a, pN3a, or pN3b. If pN0, at least one of the following criteria must be met: Pathologic tumor size > 2.0 cm; ER negative and PgR negative; Histologic and/or nuclear grade 2 (intermediate) or 3 (high); or Age < 35 years
- Patients must have undergone either a total mastectomy or breast conserving surgery (lumpectomy).
- For patients who undergo lumpectomy, the margins of the resected specimen must be histologically free of invasive tumor and ductal carcinoma in situ (DCIS) as determined by the local pathologist. If pathologic examination demonstrates tumor at the line of resection, additional operative procedures may be performed to obtain clear margins. If tumor is still present at the resected margin after re-excision(s), the patient must undergo total mastectomy to be eligible. (Patients with margins positive for lobular carcinoma in situ [LCIS] are eligible without additional resection.)
- For patients who undergo mastectomy, margins must be free of gross residual tumor. Patients with microscopic positive margins are eligible.
- Patients must have completed one of the following procedures for evaluation of pathologic nodal status: Sentinel lymphadenectomy followed by removal of additional non-sentinel lymph nodes if the sentinel node (SN) is positive; Sentinel lymphadenectomy alone if pathologic nodal staging based on sentinel lymphadenectomy is pN0, pN1mi or pN1b; or Axillary lymphadenectomy without SN isolation procedure.
- The interval between the last surgery for breast cancer (treatment or staging) and randomization must be at least 28 days but no more than 84 days.
- Patients must have ER analysis performed on the primary tumor prior to randomization. If ER analysis is negative, then PgR analysis must also be performed.
- The most recent postoperative blood counts, performed within 6 weeks prior to randomization, must meet the following criteria: ANC must be greater than or equal to 1200/mm3; Platelet count must be greater than or equal to 100,000/mm3; and Hemoglobin must be greater than or equal to 10 g/dL.
- The following criteria for evidence of adequate hepatic function must be met based on the results of the most recent postoperative tests performed within 6 weeks prior to randomization: total bilirubin must be less than or equal to upper limit of normal (ULN) for the lab unless the patient has a bilirubin elevation > ULN to 1.5 x ULN due to Gilbert's disease or similar syndrome involving slow conjugation of bilirubin; and alkaline phosphatase must be less than or equal to 2.5 x ULN for the lab; and AST must be less than or equal to 1.5 x ULN for the lab. Alkaline phosphatase and AST may not both be > the ULN.
- Patients with AST or alkaline phosphatase > ULN are eligible for inclusion in the study if liver imaging (CT, MRI, PET scan, or PET-CT scan performed within 3 months prior to randomization) does not demonstrate metastatic disease and the requirements for evidence of adequate hepatic function are met.
- Patients with alkaline phosphatase that is > ULN but less than or equal to 2.5 x ULN are eligible for inclusion in the study if a bone scan,PET scan, or PET-CT scan (performed within 3 months prior to randomization) does not demonstrate metastatic disease.
- The following criteria for renal function must be met based on the results of the most recent postoperative tests performed within 6 weeks prior to randomization: Serum creatinine must be less than or equal to ULN for the lab. Measured or calculated creatinine clearance must be > 60 mL/min.
- A urine sample must be tested for protein by determination of the urine protein/creatinine (UPC) ratio or by urine dipstick. UPC ratio must be less than 1.0. Urine dipstick must indicate 0-1+ protein. If dipstick reading is greater than or equal to 2+, determine the UPC ratio, which must be less than 1.0, or collect a 24-hour urine specimen, which must demonstrate < 1.0 g of protein per 24 hours.
- LVEF assessment must be performed within 3 months prior to randomization. The LVEF must be greater than or equal to 55% regardless of the cardiac imaging facility's lower limit of normal (LLN).
- The ECG (performed within 3 months prior to randomization) must not have demonstrated any of the following conditions: ventricular arrhythmias except for benign premature ventricular contractions; supraventricular and nodal arrhythmias requiring a pacemaker or not controlled with medication; and conduction abnormality requiring a pacemaker.
- Inflammatory breast cancer.
- Definitive clinical or radiologic evidence of metastatic disease. (Chest imaging [mandatory for all patients] and other imaging [if required] must have been performed within 3 months prior to randomization.)
- Synchronous or previous contralateral invasive breast cancer (Patients with synchronous or previous contralateral DCIS or LCIS are eligible).
- History of ipsilateral invasive breast cancer regardless of treatment or ipsilateral DCIS treated with excision and RT. (Patients with history of ipsilateral LCIS are eligible.)
- History of non-breast malignancies within the 5 years prior to study entry, except for the following: carcinoma in situ of the cervix, carcinoma in situ of the colon, melanoma in situ, and basal cell and squamous cell carcinomas of the skin.
- Previous therapy with anthracyclines, taxanes, carboplatin, trastuzumab, or bevacizumab for any malignancy.
- RT, chemotherapy, and/or targeted therapy, administered for the currently diagnosed breast cancer prior to randomization.
- Continued therapy with any hormonal agent such as raloxifene or tamoxifen (or other SERM) or an aromatase inhibitor. (Patients are eligible if these medications are discontinued prior to randomization.)
- Any sex hormonal therapy, e.g., birth control pills, ovarian hormone replacement therapy, etc. Patients are eligible if these medications are discontinued prior to randomization.
- Cardiac disease (history of and/or active disease) that would preclude the use of the drugs included in the treatment regimens. This includes but is not confined to: Active cardiac disease - angina pectoris that requires the use of anti-anginal medication; ventricular arrhythmias except for benign premature ventricular contractions; supraventricular and nodal arrhythmias requiring a pacemaker or not controlled with medication; conduction abnormality requiring a pacemaker; valvular disease with documented compromise in cardiac function; and symptomatic pericarditis. History of cardiac disease - myocardial infarction documented by elevated cardiac enzymes or persistent regional wall abnormalities on assessment of LV function; history of documented CHF; and documented cardiomyopathy.
- Uncontrolled hypertension defined as systolic blood pressure (BP) > 150 mmHg or diastolic BP > 90 mmHg, with or without anti-hypertensive medication. (BP must be assessed within 28 days prior to randomization.) Patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria.
- History of hypertensive crisis or hypertensive encephalopathy.
- History of TIA or CVA.
- History of any arterial thrombotic event within 12 months before randomization.
- Symptomatic peripheral vascular disease.
- Intrinsic lung disease resulting in dyspnea.
- Unstable diabetes mellitus.
- Active infection or chronic infection requiring chronic suppressive antibiotics.
- Any significant bleeding within 6 months before randomization, exclusive of menorrhagia in premenopausal women.
- Non-healing wound, skin ulcers, or incompletely healed bone fracture.
- Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to planned start of study therapy.
- Anticipation of need for major surgical procedures during study therapy and for at least 3 months following completion of bevacizumab.
- Gastroduodenal ulcer(s) documented by endoscopy to be active within 6 months before randomization.
- History of GI perforation, abdominal fistulae, or intra-abdominal abscess.
- Known bleeding diathesis or coagulopathy.
- Requirement for therapeutic doses of coumadin or equivalent.
- Sensory/motor neuropathy greater than or equal to grade 2, as defined by the NCI CTCAE v3.0.
- Conditions that would prohibit administration of corticosteroids.
- Chronic daily treatment with corticosteroids (dose of > 10 mg/day methylprednisolone equivalent) (excluding inhaled steroids).
- History of hypersensitivity reaction to drugs formulated with polysorbate 80.
- Pregnancy or lactation at the time of study entry. (Note: Pregnancy testing must be performed within 14 days prior to randomization according to institutional standards for women of child-bearing potential.)
- Other non-malignant systemic disease that would preclude the patient from receiving study treatment or would prevent required follow-up.
- Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements.
- Use of any investigational product within 4 weeks prior to enrollment in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2A: TH-FEC-H Docetaxel Docetaxel (T) and Trastuzumab (H) followed by 5-fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) 1B: TCHB-HB Carboplatin Docetaxel (T), Carboplatin (C), Trastuzumab (H), Bevacizumab (B) followed by Trastuzumab (T) and Bevacizumab (B) 1B: TCHB-HB Docetaxel Docetaxel (T), Carboplatin (C), Trastuzumab (H), Bevacizumab (B) followed by Trastuzumab (T) and Bevacizumab (B) 2A: TH-FEC-H 5-Fluorouracil Docetaxel (T) and Trastuzumab (H) followed by 5-fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) 1A: TCH-H Docetaxel Docetaxel (T), Carboplatin (C), and Trastuzumab (H) followed by Trastuzumab (H) 1A: TCH-H Trastuzumab Docetaxel (T), Carboplatin (C), and Trastuzumab (H) followed by Trastuzumab (H) 1A: TCH-H Carboplatin Docetaxel (T), Carboplatin (C), and Trastuzumab (H) followed by Trastuzumab (H) 1B: TCHB-HB Trastuzumab Docetaxel (T), Carboplatin (C), Trastuzumab (H), Bevacizumab (B) followed by Trastuzumab (T) and Bevacizumab (B) 1B: TCHB-HB Bevacizumab Docetaxel (T), Carboplatin (C), Trastuzumab (H), Bevacizumab (B) followed by Trastuzumab (T) and Bevacizumab (B) 2B: THB-FEC-HB Bevacizumab Docetaxel (T), Trastuzumab (H), and Bevacizumab (B) followed by 5-Fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) and Bevacizumab (B) 2A: TH-FEC-H Epirubicin Docetaxel (T) and Trastuzumab (H) followed by 5-fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) 2A: TH-FEC-H Trastuzumab Docetaxel (T) and Trastuzumab (H) followed by 5-fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) 2B: THB-FEC-HB Docetaxel Docetaxel (T), Trastuzumab (H), and Bevacizumab (B) followed by 5-Fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) and Bevacizumab (B) 2A: TH-FEC-H Cyclophosphamide Docetaxel (T) and Trastuzumab (H) followed by 5-fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) 2B: THB-FEC-HB Trastuzumab Docetaxel (T), Trastuzumab (H), and Bevacizumab (B) followed by 5-Fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) and Bevacizumab (B) 2B: THB-FEC-HB 5-Fluorouracil Docetaxel (T), Trastuzumab (H), and Bevacizumab (B) followed by 5-Fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) and Bevacizumab (B) 2B: THB-FEC-HB Epirubicin Docetaxel (T), Trastuzumab (H), and Bevacizumab (B) followed by 5-Fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) and Bevacizumab (B) 2B: THB-FEC-HB Cyclophosphamide Docetaxel (T), Trastuzumab (H), and Bevacizumab (B) followed by 5-Fluorouracil (F), Epirubicin (E), and Cyclophosphamide (C) followed by Trastuzumab (H) and Bevacizumab (B)
- Primary Outcome Measures
Name Time Method Invasive Disease-free Survival (IDFS) up to 10 years
- Secondary Outcome Measures
Name Time Method Invasive disease-free survival (IDFS) within chemotherapy cohorts up to 10 years Disease-free survival (DFS) up to 10 years Identification of biomarkers (from tumor and serum/plasma) predictive for the level of benefit from the addition of bevacizumab to standard adjuvant systemic treatment for HER2-positive breast cancer as well as for cardiac toxicity baseline, during therapy and follow-up, within 2 weeks of LVEF assessments, any protocol-specified cardiac event, and after diagnosis of recurrence Cardiac toxicity. Cumulative incidence of severe cardiac events defined as definite or probable cardiac death, or NYHA Class III or IV CHF 2-3 weeks after cycle 3; 2-3 weeks after last chemotherapy dose; 7, 10, 18, 36, and 60 months from randomization Distant recurrence-free interval (DRFI) Time from randomization until distant disease recurrence only or up to a maximum of 10 years from study entry Overall survival (OS) Time from randomization until death from any cause or up to a maximum of 10 years from study entry Non-cardiac toxicity. Frequencies of adverse events categorized using the NCI CTCAE v3.0. within 3 days of each chemotherapy cycle; 2-3 weeks following last chemotherapy dose; every 6 weeks during targeted therapy; every 6 months through year 5; every 12 months years 6 - 10 Recurrence-free interval (RFI) Time from randomization until local, regional or distant recurrence or up to a maximum of 10 years from study entry
Trial Locations
- Locations (639)
Peninsula Regional Oncology & Hematology
🇺🇸Salisbury, Maryland, United States
Associates in Oncology/Hematology
🇺🇸Rockville, Maryland, United States
The Office of Frederik Smith
🇺🇸Chevy Chase, Maryland, United States
Washington Oncology-Hematology Center, PC-Chevy Chase
🇺🇸Chevy Chase, Maryland, United States
Oncology Care Associates
🇺🇸Wheaton, Maryland, United States
Holy Cross Hospital
🇺🇸Silver Spring, Maryland, United States
Peninsula Regional Medical Center
🇺🇸Salisbury, Maryland, United States
Franklin Square Hospital Center
🇺🇸Baltimore, Maryland, United States
St. Michaels Hospital
🇨🇦Toronto, Ontario, Canada
NSABP Foundation, Inc
🇺🇸Pittsburgh, Pennsylvania, United States
UPMC Cancer Centers - UPMC St. Margaret
🇺🇸Pittsburgh, Pennsylvania, United States
Florida Cancer Specialists, Brandon
🇺🇸Brandon, Florida, United States
Oncology Associates P.C.-Hartford
🇺🇸Hartford, Connecticut, United States
North Colorado Medical Center
🇺🇸Greeley, Colorado, United States
McKee Medical Center
🇺🇸Loveland, Colorado, United States
Exempla Lutheran Medical Center
🇺🇸Wheat Ridge, Colorado, United States
Kaiser Permanente Rock Creek
🇺🇸Lafayette, Colorado, United States
Bridgeport Hospital
🇺🇸Bridgeport, Connecticut, United States
Lynn Cancer Institute
🇺🇸Boca Raton, Florida, United States
Oncology Associates P.C.-Avon
🇺🇸Avon, Connecticut, United States
Florida Cancer Specialists-Venice Island
🇺🇸Venice, Florida, United States
Northeast Georgia Cancer Care, LLC
🇺🇸Athens, Georgia, United States
Florida Cancer Specialists-Cape Coral Parkway
🇺🇸Cape Coral, Florida, United States
Phoebe Putney Memorial Hospital
🇺🇸Albany, Georgia, United States
Florida Cancer Specialists-Park Place
🇺🇸Saint Petersburg, Florida, United States
Penrose Cancer Center
🇺🇸Colorado Springs, Colorado, United States
Medical Specialists of SWIM
🇺🇸Bridgeport, Connecticut, United States
Suburban Hematology-Oncology Associates
🇺🇸Lawrenceville, Georgia, United States
Lakeland Regional Cancer Center
🇺🇸Lakeland, Florida, United States
Florida Cancer Specialists-Cape Coral Del Prado
🇺🇸Cape Coral, Florida, United States
Cancer Care Specialists-Central Illinois
🇺🇸Decatur, Illinois, United States
Florida Cancer Specialist-Cattleman
🇺🇸Sarasota, Florida, United States
Clark Medical Building
🇺🇸Jeffersonville, Indiana, United States
Michiana Hematology-Oncology, P.C. (Main Office)
🇺🇸South Bend, Indiana, United States
Michiana Hematology-Oncology, P.C. Cedar St.
🇺🇸South Bend, Indiana, United States
Emory University
🇺🇸Atlanta, Georgia, United States
Florida Cancer Specialists-Venice
🇺🇸Venice, Florida, United States
Augusta Oncology Associates
🇺🇸Augusta, Georgia, United States
Oncology Associates of Bridgeport-Fairfield
🇺🇸Fairfield, Connecticut, United States
Florida Cancer Specialists-Downtown
🇺🇸Sarasota, Florida, United States
Florida Cancer Specialists-Naples Goodlette
🇺🇸Naples, Florida, United States
Georgia Cancer Specialists
🇺🇸Marietta, Georgia, United States
Florida Cancer Specialists-Bonita Springs
🇺🇸Bonita Springs, Florida, United States
Cancer Care and Hematology Specialists of Chicagoland
🇺🇸Winfield, Illinois, United States
Florida Cancer Specialists-NAPA Ridge
🇺🇸Naples, Florida, United States
Mountain States Tumor Institute
🇺🇸Twin Falls, Idaho, United States
Northwest Georgia Oncology Centers PC
🇺🇸Cartersville, Georgia, United States
Florida Cancer Specialists, Cornerstone
🇺🇸Palm Harbor, Florida, United States
Florida Cancer Specialists-Port Charlotte
🇺🇸Port Charlotte, Florida, United States
Grady Healthsystem
🇺🇸Atlanta, Georgia, United States
Yorkville Family Practice
🇺🇸Yorkville, Illinois, United States
Corydon Hospital Medical Plaza
🇺🇸Corydon, Indiana, United States
Florida Cancer Specialists-Fort Myers Summerlin
🇺🇸Fort Myers, Florida, United States
Northern Indiana Cancer Research Consortium
🇺🇸South Bend, Indiana, United States
Florida Cancer Specialists-Fort Myers Broadway
🇺🇸Fort Myers, Florida, United States
Greater Baltimore Medical Center
🇺🇸Baltimore, Maryland, United States
Mercy Medical Center
🇺🇸Baltimore, Maryland, United States
Hematology-Oncology Associates
🇺🇸Baltimore, Maryland, United States
University of Iowa
🇺🇸Iowa City, Iowa, United States
Elkhart Clinic
🇺🇸Elkhart, Indiana, United States
Cancer Care & Hematology Specialists of Chicagoland
🇺🇸Arlington, Illinois, United States
Berkshire Hematology Oncology, P.C.-North Adams
🇺🇸North Adams, Massachusetts, United States
Crossroads Cancer Center
🇺🇸Decatur, Illinois, United States
Edward Hospital
🇺🇸Naperville, Illinois, United States
CCOP, St. John Hospital and Medical Center
🇺🇸Grosse Pointe Woods, Michigan, United States
Cancer Care of Southern Indiana
🇺🇸Bloomington, Indiana, United States
Howard Regional Health System
🇺🇸Kokomo, Indiana, United States
Josephone Ford Cancer Center
🇺🇸Brownstown, Michigan, United States
Rush University Medical Center
🇺🇸Chicago, Illinois, United States
Sing and Arora
🇺🇸Flint, Michigan, United States
Edward Cancer Center Plainfield
🇺🇸Plainfield, Illinois, United States
Cancer Care Center
🇺🇸New Albany, Indiana, United States
Berkshire Hematology Oncology, P.C.
🇺🇸Pittsfield, Massachusetts, United States
Bay Regional Medical Center
🇺🇸Bay City, Michigan, United States
Waverly Hematology Oncology
🇺🇸Gary, Indiana, United States
Decatur Memorial Hospital
🇺🇸Decatur, Illinois, United States
St. Mary's Health Services
🇺🇸Grand Rapids, Michigan, United States
Michiana Hematology-Oncology, P.C. (Elkhart)
🇺🇸Elkhart, Indiana, United States
Minnesota Oncology Hematology-Burnsville
🇺🇸Burnsville, Minnesota, United States
Providence Medical Group
🇺🇸Terre Haute, Indiana, United States
UP Hematology/Oncology Assoc.-Doctor's Park Family Physicians
🇺🇸Escanaba, Michigan, United States
Portage Internal Medical Associates
🇺🇸Hancock, Michigan, United States
South Bend Clinic
🇺🇸South Bend, Indiana, United States
Harry & Jeannette Weinberg Cancer Institute
🇺🇸Baltimore, Maryland, United States
Bixby Medical Center
🇺🇸Adrian, Michigan, United States
St. Joseph Mercy Woodland Health Center
🇺🇸Brighton, Michigan, United States
Alpine Hematology-Oncology
🇺🇸Reno, Nevada, United States
Genesys Regional Medical Center
🇺🇸Grand Blanc, Michigan, United States
Lapeer Regional Hospital
🇺🇸Lapeer, Michigan, United States
Genesys Hurley
🇺🇸Flint, Michigan, United States
St. John's Regional Health Center-Joplin
🇺🇸Joplin, Missouri, United States
Metro Health Hospital
🇺🇸Wyoming, Michigan, United States
CCOP Hurley Medical Center
🇺🇸Flint, Michigan, United States
Henry Ford Medical Center-Fairlane
🇺🇸Dearborn, Michigan, United States
St. Luke's-Roosevelt Hospital Center
🇺🇸New York, New York, United States
CCOP Presbyterian Hospital
🇺🇸Charlotte, North Carolina, United States
Interlakes Oncology & Hematology, P.C.
🇺🇸Canandaigua, New York, United States
NY Oncology Hematology PC- Latham- Capital District Oncology Hematology
🇺🇸Latham, New York, United States
Keewanaw Memorial Hospital
🇺🇸Laurium, Michigan, United States
Troy Cancer Treatment Program
🇺🇸Troy, New York, United States
University of Missouri-Ellis Fischel
🇺🇸Columbia, Missouri, United States
Grand Rapids Clinical Oncology Program
🇺🇸Grand Rapids, Michigan, United States
Hubert H. Humphrey Cancer Center - Coon Rapids
🇺🇸Coon Rapids, Minnesota, United States
Hematology Oncology Centers of the Northern Rockies
🇺🇸Billings, Montana, United States
Hubert H. Humphrey Cancer Center-Robbinsdale
🇺🇸Robbinsdale, Minnesota, United States
University of Tennessee Cancer Institute
🇺🇸Southaven, Mississippi, United States
St. John's Regional Health Center
🇺🇸Springfield, Missouri, United States
West Michigan Cancer Center
🇺🇸Kalamazoo, Michigan, United States
CCOP, Sparrow Health System
🇺🇸Lansing, Michigan, United States
Carolinas Hematology-Oncology Associates - Tyron St
🇺🇸Charlotte, North Carolina, United States
Renown Regional Medical Center
🇺🇸Reno, Nevada, United States
Hematology Oncology Assaociates of CNY, CCOP
🇺🇸East Syracuse, New York, United States
St. Mary Mercy Hospital - Livonia
🇺🇸Livonia, Michigan, United States
Park Nicollet Clinic
🇺🇸Burnsville, Minnesota, United States
Beth Israel Medical Center
🇺🇸New York, New York, United States
Minnesota Oncology Hematology PA - Maplewood
🇺🇸Maplewood, Minnesota, United States
New York Oncology Hematology PC-Albany
🇺🇸Albany, New York, United States
Freeman Cancer Institute
🇺🇸Joplin, Missouri, United States
CCOP, Mission Hospitals, Inc.
🇺🇸Asheville, North Carolina, United States
Henry Ford Medical Center-West Bloomfield
🇺🇸West Bloomfield, Michigan, United States
Fairview Southdale Medical Oncology Clinic
🇺🇸Edina, Minnesota, United States
Alliance Cancer Center
🇺🇸Alliance, Ohio, United States
NY Oncology Hematology PC-Hudson Carvell Cancer Tx Prog.
🇺🇸Hudson, New York, United States
Hematology Oncology Associates of CNY, CCOP
🇺🇸Rome, New York, United States
Comprehensive Cancer Centers of Nevada (Siena)
🇺🇸Henderson, Nevada, United States
Minnesota Oncology Hematology-Edina
🇺🇸Edina, Minnesota, United States
Minnesota Oncology Hematology-Waconia
🇺🇸Waconia, Minnesota, United States
Aultman Hospital
🇺🇸Canton, Ohio, United States
Mecklenburg Medical Group - Morehead Medical Dr
🇺🇸Charlotte, North Carolina, United States
Riverview Cancer Care Medical Association
🇺🇸Rexford, New York, United States
Mecklenburg Medical Group - Cameron Valley Pkwy
🇺🇸Charlotte, North Carolina, United States
NY Oncology Hematology PC at Albany Medical Center
🇺🇸Albany, New York, United States
Cancer Center of NC at Asheville
🇺🇸Asheville, North Carolina, United States
Dayton Physicians, LLC - Greenville
🇺🇸Greenville, Ohio, United States
Geisinger Clinic
🇺🇸Danville, Pennsylvania, United States
Toledo Clinic
🇺🇸Toledo, Ohio, United States
Amsterdam Community Cancer Program
🇺🇸Amsterdam, New York, United States
Hamilton Office
🇺🇸Hamilton, Ohio, United States
Flower Memorial Hospital
🇺🇸Sylvania, Ohio, United States
Hematology Oncology Assoc. of CNY, CCOP (Comm. General Hospital Satellite Office)
🇺🇸Syracuse, New York, United States
Carolinas Hematology Oncology Associates - Harris Blvd.
🇺🇸Charlotte, North Carolina, United States
Cancer Care of Western North Carolina
🇺🇸Asheville, North Carolina, United States
UPMC Cancer Centers Arnold Palmer Pavilion-Mountainview
🇺🇸Greensburg, Pennsylvania, United States
Riddle Memorial Hospital
🇺🇸Media, Pennsylvania, United States
UHHS - Chagrin Highlands
🇺🇸Orange Village, Ohio, United States
Akron General Medical Center
🇺🇸Akron, Ohio, United States
Scranton Hematology Oncology
🇺🇸Scranton, Pennsylvania, United States
UPMC Cancer Centers Arnold Palmer-Oakbrook
🇺🇸Greensburg, Pennsylvania, United States
UHHS Green Road-Ireland Cancer Center
🇺🇸South Euclid, Ohio, United States
Lehigh Valley Hospital
🇺🇸Allentown, Pennsylvania, United States
Northwest Ohio Oncology Center
🇺🇸Maumee, Ohio, United States
Hillman Cancer Center
🇺🇸Pittsburgh, Pennsylvania, United States
Akron City Hospital
🇺🇸Akron, Ohio, United States
Carolinas Hematology-Oncology - John J. Delaney
🇺🇸Charlotte, North Carolina, United States
Healthplex
🇺🇸Fairfield, Ohio, United States
UPMC Cancer Centers-John P. Murtha Cancer Center
🇺🇸Johnstown, Pennsylvania, United States
Kimmel Cancer Center at Jefferson
🇺🇸Philadelphia, Pennsylvania, United States
Bayview Oncology Associates
🇺🇸Toledo, Ohio, United States
UPMC Cancer Centers - McKeesport Hospital
🇺🇸McKeesport, Pennsylvania, United States
Allegheny General Hospital/Allegheny-Singer Research Institute
🇺🇸Pittsburgh, Pennsylvania, United States
Hematology Oncology Associates of NE PA
🇺🇸Donora, Pennsylvania, United States
The Center for Cancer and Blood Disorders
🇺🇸Fort Worth, Texas, United States
Ephrata Cancer Center at Ephrata Community Hospital
🇺🇸Ephrata, Pennsylvania, United States
Cancer Center at Center One
🇺🇸Philadelphia, Pennsylvania, United States
UPMC Cancer Centers-Indiana
🇺🇸Indiana, Pennsylvania, United States
Albert Einstein Healthcare Network
🇺🇸Philadelphia, Pennsylvania, United States
Mercy Hospital
🇺🇸Scranton, Pennsylvania, United States
UPMC Cancer Centers Arnold Palmer-Mt. Pleasant
🇺🇸Mount Pleasant, Pennsylvania, United States
McKay-Dee Hospital
🇺🇸Ogden, Utah, United States
Universitatsfrauenklinik Graz
🇦🇹Graz, Austria
North Shore Private Hospital
🇦🇺St. Leonards, New South Wales, Australia
Royal North Shore Hospital
🇦🇺St. Leonards, New South Wales, Australia
Johanniter Krankenhaus
🇩🇪Stendal, Germany
Tartu University Hospital Clinic of Hematology and Oncology
🇪🇪Tartu, Estonia
Jilin Cancer Hospital
🇨🇳Changchun, China
Sun Yat-sen University Hospital
🇨🇳Guangzhou, China
CH-Service Hemato-Oncologie
🇫🇷Beauvais, France
Fachärzte fürlnnere Medizin, Hämatologie
🇩🇪Traunstein, Germany
Kreiskrankenhaus Hameln
🇩🇪Hameln, Germany
FN Na Bulovce
🇨🇿Praha 8, Czechia
Ev Krankenhaus Bethesda
🇩🇪Mönchengladbach, Germany
Universitaetsklinikum Munster
🇩🇪Munster, Germany
IRCCS - Instituto Nazionale per lo Studio e la Cura
🇮🇹Napoli, Italy
Universita-istituto Clinica Medica
🇮🇹Sassari, Italy
Zentrum fur Frauenheilkunde und Geburtshilfe
🇩🇪Frankfurt, Germany
Universitaetsklinikum Mainz
🇩🇪Mainz, Germany
RotKreuzKlinikum München GmbH
🇩🇪Munich, Germany
Medizinisches Versorgungszentrum Osthessen
🇩🇪Fulda, Germany
Luisenkrankenhaus
🇩🇪Duesseldorf, Germany
Regina Elena Cancer Institute
🇮🇹Rome, Italy
Ospedale casa sollievo della sofferenza
🇮🇹San-Giovanni, Italy
CHU D'Amiens
🇫🇷Amiens, France
St. Vincenz u. Elisabeth Hospital
🇩🇪Mainz, Germany
CHU Morvan
🇫🇷Brest, France
Hopital Pasteur
🇫🇷Colmar, France
Centre Regional de Lutte contre le Cancer (CRLC) Val d'Aurelle
🇫🇷Montpellier, France
Universitat Frauenklinik Jena
🇩🇪Jena, Germany
Severance Hospital
🇰🇷Seoul, Korea, Republic of
Asan Medical Center
🇰🇷Seoul, Korea, Republic of
Onkologische schwerpunktpraxis
🇩🇪Leer, Germany
Klinikum Chemnitz
🇩🇪Chemnitz, Germany
Klinikum Rosenheim
🇩🇪Rosenheim, Germany
Humanitas Centro Catanese
🇮🇹Catania, Italy
(Azienda u.s.I. chieti) - Policinico Ospedaliero
🇮🇹Chieti, Italy
Ospedale di Mirano
🇮🇹Mirano, Italy
Institut Daniel Hollard
🇫🇷Grenoble, France
CHU Dupuytren
🇫🇷Limoges, France
Hopital St. Joseph
🇫🇷Marseille, France
Klinikum Lippe Lemgo
🇩🇪Lemgo, Germany
Klinikverbund Suedwest - Sindelfingen-Böeblingen Clinical Centre
🇩🇪Böeblingen, Germany
Klinikum Stadt Hanau
🇩🇪Hanau, Germany
Asklepios Kliniken Lich GmbH
🇩🇪Lich, Germany
Praxis und Tagesklinik fuer Onkologie und
🇩🇪Recklinghausen, Germany
Clinique Hartmann
🇫🇷Neuilly sur Seine, France
St. Vincent's University Hospital
🇮🇪Dublin 4, Ireland
University College Hospital Galway
🇮🇪Galway, Ireland
Ospedale vito fazzi
🇮🇹Lecce, Italy
Clinique Bordeaux Nord Aquitaine
🇫🇷Bordeaux, France
Universitaetsklinikum Dresden
🇩🇪Dresden, Germany
Klinikum St. Marien Amberg
🇩🇪Amberg, Germany
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of
Klinikum Hannover Nordstadt
🇩🇪Hannover, Germany
Robert-Bosch-Krankenhaus
🇩🇪Stuttgart, Germany
Universitaetsfrauenklinik
🇩🇪Essen, Germany
Fondazione Salvatore Maugeri
🇮🇹Pavia, Italy
Sahlgrenska University Hospital
🇸🇪Goteborg, Sweden
Karolinska University Hospital
🇸🇪Stockholm, Sweden
Ospedale S. Filippo Neri
🇮🇹Roma, Italy
Hospital Universitario Gregorio Maranon
🇪🇸Madrid, Spain
Hospital Comarcal de Barbastro
🇪🇸Barbastro, Spain
Seoul National University Bundang Hospital
🇰🇷Gyeonggi-do, Korea, Republic of
Hospital Gral. De Elche
🇪🇸Elche, Spain
Fundacion Hospitalaria de Alcorcon
🇪🇸Alcorcon, Spain
Consorci Sanitari de Terrassa
🇪🇸Barcelona, Spain
Complejo Hospitalario de Jaen
🇪🇸Jaen, Spain
Hospital General de Alicante
🇪🇸Alicante, Spain
Hospital Perpetuo Socorro
🇪🇸Badajoz, Spain
Bristol Hematology - Oncology Centre
🇬🇧Bristol, United Kingdom
Sunrise Cancer Centre
🇬🇧Truro, United Kingdom
Hospital Univesitario Carlos Haya
🇪🇸Malaga, Spain
Centro Integral de Oncologia "Clara Campal"
🇪🇸Madrid, Spain
Centro Oncologico de Galicia
🇪🇸La Coruña, Spain
Christie Hospital NHS Trust
🇬🇧Manchester, United Kingdom
Hospital Clinico Virgen de la Victoria
🇪🇸Malaga, Spain
Johannesburg Hospital
🇿🇦Johannesburg, South Africa
Hospital Xera Calde
🇪🇸Lugo, Spain
Hospital Universitario San Carlos
🇪🇸Madrid, Spain
Hospital Universitario de Canarias
🇪🇸La Laguna, Spain
Nottingham City Hospital
🇬🇧Nottingham, United Kingdom
Hopelands Cancer Centre
🇿🇦Durban, South Africa
Hospital De San Pedro de Alcantara
🇪🇸Caceres, Spain
Hospital del Parc Tauli
🇪🇸Sabadell, Spain
Complejo Hospitalario Universitario A Coruna
🇪🇸La Coruna, Spain
Hospital Clinic i Provincial
🇪🇸Barcelona, Spain
Hospital Ruber International
🇪🇸Madrid, Spain
Instituto Oncologico de Guipuzcoa
🇪🇸San Sebastian, Spain
Hospital Germans Trias l Pujol
🇪🇸Badalona (Barcelona), Spain
Songklanagarind Hospital
🇹ðŸ‡Songkhla, Thailand
Hospital U. Miguel Servet
🇪🇸Zaragoza, Spain
Ipswich Hospital
🇬🇧Ipswich, United Kingdom
Hospital Del Mar
🇪🇸Barcelona, Spain
Hospital Universitario Insular de Gran Canaria
🇪🇸Las Palmas, Canary Islands, Spain
Hospital de Cabueñes, Oncologia Médica
🇪🇸Gijon, Spain
Hospital Santa Crue l San Pau
🇪🇸Barcelona, Spain
Instituto Catalan Oncologia de Girona
🇪🇸Girona, Spain
Hospital Universitario de Salamanca
🇪🇸Salamanca, Spain
National Cheng Kung University
🇨🇳Tainan, Taiwan
Royal Bournemouth Hospital
🇬🇧Bournemouth, United Kingdom
Hospital Clinico Universitario Lozano Blesa
🇪🇸Zaragoza, Spain
Baylor College of Medicine
🇺🇸Houston, Texas, United States
Chinese Academy of Medical Science
🇨🇳Beijing, China
Fuzhou General Hospital of Nanjing Military Area
🇨🇳Fuzhou, China
1st Affiliated Hospital of Zhejiang University
🇨🇳Hangzhou, China
Zhejiang Tumor Hospital
🇨🇳Hangzhou, China
Tianjin Cancer Hospital
🇨🇳Tianjin, China
William Stanton, MD, Inc
🇺🇸San Diego, California, United States
Minnesota Oncology Hematology-Minneapolis
🇺🇸Minneapolis, Minnesota, United States
Cancer and Blood Specialists- Shadow Lane
🇺🇸Las Vegas, Nevada, United States
Cancer Consultants
🇺🇸Las Vegas, Nevada, United States
Kenwood Office
🇺🇸Cincinnati, Ohio, United States
Oncology/Hematology Care Clinical Trials LLC
🇺🇸Cincinnati, Ohio, United States
North Treatment Center - Blue Ash Medical Center
🇺🇸Cincinnati, Ohio, United States
Oncology/Hematology Care Clinical Trials LLC, Cincinnati, OH Blue Ash Med. Cntr. (Administrative Only)
🇺🇸Cincinnati, Ohio, United States
Chulalongkorn Hospital
🇹ðŸ‡Patumwan, Bangkok, Thailand
Berdat Family Comprehensive Cancer Centre
🇦🇺Subiaco, Western Australia, Australia
Lawrence Memorial Hospital
🇺🇸Lawrence, Kansas, United States
Newark Beth Israel Medical Center
🇺🇸Newark, New Jersey, United States
Lakeside Cancer Specialists, PLLC
🇺🇸Saint Joseph, Michigan, United States
CCOP, St. Mary's Medical Center
🇺🇸Saginaw, Michigan, United States
Clearview Cancer Institute-Decatur
🇺🇸Decatur, Alabama, United States
Clearview Cancer Institute
🇺🇸Huntsville, Alabama, United States
Clearview Cancer Institute- Huntsville
🇺🇸Huntsville, Alabama, United States
Comprehensive Blood and Cancer Center
🇺🇸Bakersfield, California, United States
Central Hematology/Oncology Medical Group, Inc.
🇺🇸Alhambra, California, United States
Kaiser Permanente-Bellflower
🇺🇸Bellflower, California, United States
Kaiser Permanente-Baldwin Park
🇺🇸Baldwin Park, California, United States
Hematology-Encinitas
🇺🇸Encinitas, California, United States
Providence Saint Joseph Medical Center
🇺🇸Burbank, California, United States
Scripps Clinic Encinitas
🇺🇸Encinitas, California, United States
St. Jude Heritage Healthcare
🇺🇸Fullerton, California, United States
Kaiser Permanente-Fontana
🇺🇸Fontana, California, United States
Pacific Shores Medical Group
🇺🇸Huntington Beach, California, United States
Scripps Cancer Center-San Diego
🇺🇸La Jolla, California, United States
Kaiser Permanente-Irvine
🇺🇸Irvine, California, United States
Hematology-La Jolla
🇺🇸La Jolla, California, United States
Sabina R. Wallach, MD., AMC
🇺🇸La Jolla, California, United States
Antelope Valley Cancer Center
🇺🇸Lancaster, California, United States
North County Oncology Medical Clinic, Inc.
🇺🇸Oceanside, California, United States
Kaiser Permanente-Panorama City
🇺🇸Panorama City, California, United States
Kaiser Permanente-Sunset
🇺🇸Los Angeles, California, United States
Kaiser Permanente-West Los Angeles
🇺🇸Los Angeles, California, United States
Kaiser Permanente-Oakland
🇺🇸Oakland, California, United States
Kaiser Permanente-Orange County
🇺🇸Panorama City, California, United States
Wilshire Oncology Medical Group
🇺🇸Pasadena, California, United States
Cancer Care Associates Medical Group, Inc.
🇺🇸Redondo Beach, California, United States
Kaiser Permanente-Riverside
🇺🇸Riverside, California, United States
Kaiser Permanente-Sacramento
🇺🇸Roseville, California, United States
Kaiser Permanente-Roseville
🇺🇸Roseville, California, United States
Sutter Roseville Medical Center
🇺🇸Roseville, California, United States
Peter T. Reissman, MD, Inc
🇺🇸San Diego, California, United States
Kaiser Permanente-San Diego
🇺🇸San Diego, California, United States
Sharp Rees-Stealy
🇺🇸San Diego, California, United States
Scripps Clinic-Rancho Bernardo
🇺🇸San Diego, California, United States
Kaiser Permanente-San Francisco
🇺🇸San Francisco, California, United States
Kaiser Permanente-Hayward
🇺🇸San Francisco, California, United States
Sansum Clinic
🇺🇸Santa Barbara, California, United States
Kaiser Permanente-Santa Clara
🇺🇸Santa Clara, California, United States
Santa Barbara Hematology Oncology Medical Group
🇺🇸Santa Barbara, California, United States
Stanford University Medical Center
🇺🇸Stanford, California, United States
Central Coast Medical Oncology Corporation
🇺🇸Santa Maria, California, United States
UCLA/Santa Clarita Valley Cancer Center
🇺🇸Valencia, California, United States
Kaiser Permanente-South San Francisco
🇺🇸South San Francisco, California, United States
Kaiser Permanente-Vallejo
🇺🇸Vallejo, California, United States
San Diego Pacific Oncology & Hematology-Vista
🇺🇸Vista, California, United States
Kaiser Permanente-Walnut Creek
🇺🇸Walnut Creek, California, United States
Kaiser Permanente-Woodland Hills
🇺🇸Woodland Hills, California, United States
Hematology and Oncology Associates
🇺🇸Scranton, Pennsylvania, United States
UPMC Cancer Centers - Wexford
🇺🇸Wexford, Pennsylvania, United States
UPMC Cancer Centers-Uniontown
🇺🇸Uniontown, Pennsylvania, United States
Thompson Cancer Survival Center-Dowell Springs
🇺🇸Knoxville, Tennessee, United States
Texas Oncology- Sammons CC
🇺🇸Dallas, Texas, United States
Ben Taub General Hospital
🇺🇸Houston, Texas, United States
Covenant Health System dba Joe Arrington Cancer Research & Treatment Center
🇺🇸Lubbock, Texas, United States
North Texas Regional Cancer Center
🇺🇸Plano, Texas, United States
Intermountain Medical Center
🇺🇸Murray, Utah, United States
Utah Valley Regional Medical Center
🇺🇸Provo, Utah, United States
Dixie Medical Center
🇺🇸Saint George, Utah, United States
LDS Hospital
🇺🇸Salt Lake City, Utah, United States
Overlake Internal Medicine
🇺🇸Bellevue, Washington, United States
Rockwood Cancer Treatment Center - Sinto Ave
🇺🇸Spokane, Washington, United States
Rockwood Cancer Treatment Center
🇺🇸Spokane, Washington, United States
Southwest Washington Hospital
🇺🇸Vancouver, Washington, United States
Northwest Cancer Specialists-136th Ave
🇺🇸Vancouver, Washington, United States
Northwest Cancer Specialists-134th St.
🇺🇸Vancouver, Washington, United States
Oncology Alliance-Burlington
🇺🇸Burlington, Wisconsin, United States
Oncology Alliance
🇺🇸Glendale, Wisconsin, United States
Aurora BayCare Medical Center
🇺🇸Green Bay, Wisconsin, United States
Oncology Alliance-Kenosha South
🇺🇸Kenosha, Wisconsin, United States
Oncology Alliance-Kenosha North
🇺🇸Kenosha, Wisconsin, United States
CCOP, Marshfield Clinic
🇺🇸Marshfield, Wisconsin, United States
Oncology Alliance-Menomonee Falls
🇺🇸Menomonee Falls, Wisconsin, United States
Oncology Alliance-Mequon
🇺🇸Mequon, Wisconsin, United States
Oncology Alliance-Waukeska
🇺🇸Waukesha, Wisconsin, United States
Oncology Alliance-Racine
🇺🇸Racine, Wisconsin, United States
Marshfield Clinic Weston Center
🇺🇸Weston, Wisconsin, United States
Macarthur Cancer Center
🇦🇺Campbelltown, New South Wales, Australia
St. George Hospital
🇦🇺Kogarah, New South Wales, Australia
Cancer Therapy Center
🇦🇺Liverpool, New South Wales, Australia
Southern Medical Day Care
🇦🇺Wollongong, New South Wales, Australia
Royal Brisbane & Women's Hospital
🇦🇺Herston, Queensland, Australia
Mater Adult Hospital
🇦🇺South Brisbane, Queensland, Australia
Ashford Cancer Center
🇦🇺Ashford, South Australia, Australia
Flinders Medical Centre
🇦🇺Bedford, South Australia, Australia
Frankston Hospital
🇦🇺Frankston, Victoria, Australia
The Alfred Hospital
🇦🇺Melbourne, Victoria, Australia
Mount Medical Center
🇦🇺Perth, Western Australia, Australia
AI University Hospital Innsbruck
🇦🇹Innsbruck, Austria
Bezirkskrankenhaus Kufstein, Innere Medizin
🇦🇹Kufstein, Austria
Landeskrankenhaus Leoben, Abteilung fur Haemato-Onkologie
🇦🇹Leoben, Austria
Krankenhaus Barmherzige Schwestern Linz, Kooperative Studiengruppe, Chirurgie
🇦🇹Linz, Austria
AI Universitätsklinikum der PMU Landeskliniken
🇦🇹Salzburg, Austria
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
Medizinische Universitaet Wien-Allgemeines Krankenhaus, Onkologie
🇦🇹Vienna, Austria
Henry Ford Hospital
🇺🇸Detroit, Michigan, United States
Krankenhaus Hietzing, Gynaekologische Abteilung
🇦🇹Vienna, Austria
Landeskrankenhaus Voecklabruck, 2. Medizinische Abteilung
🇦🇹Voecklabruck, Austria
Clinical Centre University of Sarajevo
🇧🇦Sarajevo, Bosnia and Herzegovina
Centro Goiano de oncologia
🇧🇷Goiania, GO, Brazil
Assoiacao hospital de caridade de ijui
🇧🇷Ijui, RS, Brazil
Lifecenter Sistema de Saude S/A
🇧🇷Belo Horizonte, MG, Brazil
Hospital Das Clinicas de Porto Alegre-HCPA
🇧🇷Porto Alegre, RS, Brazil
Irmandade da Santa Casa de Misericoria de Porto Alegre Nucleo de Novos Tratamentos
🇧🇷Porto Alegre, RS, Brazil
Clinica de Oncologia de Porto Alegre
🇧🇷Porto Alegre, RS, Brazil
Fundacao Dr. Amaral Carvalho
🇧🇷Jau, SP, Brazil
Centro de Oncologia e Hematologia da Faculdade de Medicina do ABC
🇧🇷Santo Andre, SP, Brazil
Instituto do Cancer de Sao Paulo
🇧🇷Sao Paulo, SP, Brazil
Conjunto Hospitalar de Sorocaba
🇧🇷Sorocaba, Brazil
MHAT "Tsaritsa Yoanna-ISUL" EOOD
🇧🇬Sofia, Bulgaria
Dr. H. Bliss Murphy Cancer Centre
🇨🇦St. Johns, Newfoundland and Labrador, Canada
William Osler Health Center
🇨🇦Brampton, Ontario, Canada
Credit Valley Hospital
🇨🇦Mississauga, Ontario, Canada
Southlake Regional Health Centre
🇨🇦New Market, Ontario, Canada
The Pla 307 Hospital
🇨🇳Beijing, China
Chinese PLA General Hospital
🇨🇳Beijing, China
West China Hospital, Sichuan University
🇨🇳Chengdu, China
Ch intercommunal de creteil
🇫🇷Creteil, France
Centre Leonard de Vinci
🇫🇷Dechy, France
Clinique Francois Chenieux
🇫🇷Limoges, France
CHU Hotel Dieu
🇫🇷Paris, France
Clinique Saint Hilaire
🇫🇷Rouen, France
Pole de cancerologie prive
🇫🇷Strasbourg, France
Institution Claudius Regaud
🇫🇷Toulouse Cedex, France
Department of Oncotherapy National Hospital
🇿🇦Bloemfontein, South Africa
Hospital Torrevieja Salud, UTE
🇪🇸Torrevieja, Spain
Kaiser Permanente-Franklin
🇺🇸Denver, Colorado, United States
Cypress Hematology/Oncology
🇺🇸Denver, Colorado, United States
Rocky Mountain Cancer Center - Midtown
🇺🇸Denver, Colorado, United States
CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only)
🇺🇸Denver, Colorado, United States
Providence Oncology and Hematology Care Clinic
🇺🇸Portland, Oregon, United States
Adventist Medical Center
🇺🇸Portland, Oregon, United States
Northwest Cancer Specialists-Portland
🇺🇸Portland, Oregon, United States
Providence Portland Medical Center
🇺🇸Portland, Oregon, United States
Northwest Cancer Specialists-Adventist Office
🇺🇸Portland, Oregon, United States
CCOP, Columbia River Oncology
🇺🇸Portland, Oregon, United States
Providence St. Vincent Medical Center
🇺🇸Portland, Oregon, United States
CHD les Oudairies
🇫🇷La Roche sur Yon Cedex, France
Centre Catherine de Sienne
🇫🇷Nantes Cedex, France
Breast Cancer Clinic
🇵🇱Warsaw, Poland
Hopital St. Antoine
🇫🇷Paris Cedex 12, France
CLCC Paul Strauss
🇫🇷Strasbourg, France
Polyclinique du Parc
🇫🇷Toulous, France
Asl n. 5 -Ospedale s. Vincenzo
🇮🇹Taormina, Italy
Oncology Associates of Bridgeport-Trumbull
🇺🇸Trumbull, Connecticut, United States
Hartford Hospital
🇺🇸Hartford, Connecticut, United States
Washington Cancer Institute
🇺🇸Washington, District of Columbia, United States
Oncology Associates P.C.-Willimantic
🇺🇸Willimantic, Connecticut, United States
Northern Arizona Hematology & Onclogy Associates
🇺🇸Flagstaff, Arizona, United States
Eastern Connecticut Hematology & Oncology Associates
🇺🇸Norwich, Connecticut, United States
Medical Specialists of Fairfield
🇺🇸Fairfield, Connecticut, United States
Medical Oncology and Hematology, P.C.
🇺🇸Meriden, Connecticut, United States
Sibley Memorial Hospital
🇺🇸Washington, District of Columbia, United States
Connecticut Multi Specialty Group-Hartford
🇺🇸Hartford, Connecticut, United States
Medical Oncology & Hematology, P.C.
🇺🇸Waterbury, Connecticut, United States
Black Rock Medical Group
🇺🇸Trumbull, Connecticut, United States
Washington Oncology-Hematology Center, PC-Washington
🇺🇸Washington, District of Columbia, United States
Connecticut Multi Specialty Group-Wethersfield
🇺🇸Wethersfield, Connecticut, United States
CCOP, Christiana Care Health Services Inc.
🇺🇸Newark, Delaware, United States
Kootenai Cancer Center
🇺🇸Coeur d'Alene, Idaho, United States
Baton Rouge General Medical Center
🇺🇸Baton Rouge, Louisiana, United States
Eastern Maine Medical Center
🇺🇸Bangor, Maine, United States
Cancer Institute of New Jersey
🇺🇸New Brunswick, New Jersey, United States
Sparta Cancer Treatment Center
🇺🇸Sparta, New Jersey, United States
University Medical Center of Southern Nevada
🇺🇸Las Vegas, Nevada, United States
Cancer Institute of New Jersey at Hamilton
🇺🇸Hamilton, New Jersey, United States
Nevada Cancer Institute
🇺🇸Las Vegas, Nevada, United States
The West Clinic
🇺🇸Memphis, Tennessee, United States
Overlook Hospital
🇺🇸Summit, New Jersey, United States
Cox Health Systems
🇺🇸Springfield, Missouri, United States
University of Medicine and Dentistry of New Jersey
🇺🇸Newark, New Jersey, United States
West Virginia University Hospitals Inc.
🇺🇸Morgantown, West Virginia, United States
Krankenhaus Barmherzige Brueder Graz, Medizinische Abteilung
🇦🇹Graz, Austria
AKH Vienna
🇦🇹Vienna, Austria
Jewish General Hospital
🇨🇦Montreal, Quebec, Canada
Thompson Oncology Group-Blount
🇺🇸Knoxville, Tennessee, United States
Thompson Oncology Group-West
🇺🇸Knoxville, Tennessee, United States
Morristown Memorial Hospital
🇺🇸Morristown, New Jersey, United States
Summit Medical Group
🇺🇸Berkeley Heights, New Jersey, United States
Hospital Universitario Austral
🇦🇷Derqui, Buenos Aires, Argentina
Centro Oncologico Rosario (COR)
🇦🇷Rosario, Sante Fe, Argentina
Drs. Forte, Schleider, Attas and Condemi, PA
🇺🇸Englewood, New Jersey, United States
Monmouth Medical Center
🇺🇸Long Branch, New Jersey, United States
University of Pittsburgh
🇺🇸Pittsburgh, Pennsylvania, United States
Breast Clinica de la mama
🇦🇷La Plata, Buenos Aires, Argentina
CEMIC
🇦🇷Buenos Aires, Argentina
C. H. Notre-Dame and Reine Fabiola
🇧🇪Charleroi, Belgium
Clinique St Pierre
🇧🇪Ottignies, Belgium
Hopital Maisonneuve Rosemont
🇨🇦Montreal, Quebec, Canada
Hospital du Sacre-Coeur
🇨🇦Montreal, Quebec, Canada
University Hospital Zagreb
ðŸ‡ðŸ‡·Zagreb, Croatia
St. James's Hospital
🇮🇪Dublin, Ireland
Ziv Medical Center
🇮🇱Zefat, Israel
Lion's Gate Hospital
🇨🇦North Vancouver, British Columbia, Canada
Thompson Cancer Survival Center
🇺🇸Knoxville, Tennessee, United States
York Hospital
🇺🇸York, Pennsylvania, United States
Klinikum Wels-Grieskirchen, Kooperative Gruppe Wels/4. Medizinische Abteilung
🇦🇹Wels, Austria
District Oncology Dispensary Plovdiv
🇧🇬Plovdiv, Bulgaria
Centre Hospitalier Affilie Universitaire De Quebec, Hospital du St-Sacrement
🇨🇦Quebec City, Quebec, Canada
Semmelweis Egyetem Clinic of Radiology
ðŸ‡ðŸ‡ºBudapest, Hungary
Hospital Britanico de Buenos Aires
🇦🇷Buenos Aires, Argentina
Medizinische Universitat Graz - Onkologie
🇦🇹Graz, Austria
AZ Klina
🇧🇪Brasschaat, Belgium
Hopital Charles LeMoyne
🇨🇦Greenfield Park, Quebec, Canada
University of Montreal Hospital Group
🇨🇦Montreal, Quebec, Canada
National Cancer Institute
🇹ðŸ‡Bangkok, Thailand
Royal Victoria Hospital
🇨🇦Montreal, Quebec, Canada
Medical Institute St. Augustinus
🇧🇪Wilrijk, Belgium
Tom Baker Cancer Centre
🇨🇦Calgary, Alberta, Canada
Montreal General Hospital
🇨🇦Montreal, Quebec, Canada
Hospital Regional Rancagua
🇨🇱Rancagua, VI Region, Chile
The Lady Davis Carmel Medical Center/Lynn
🇮🇱Haifa, Israel
Kaplan Medical Center
🇮🇱Rehovot, Israel
Saint-Petersburg State Medical Institution "City Clinical Oncology Dispensary"
🇷🇺Saint Petersburg, Russian Federation
University Clinical Centre
🇸🇮Maribor, Slovenia
P.G. Hospital of Thessaloniki "Papageorgiou"
🇬🇷Thessaloniki, Greece
Queen Elizabeth Hospital
ðŸ‡ðŸ‡°Hong Kong, Hong Kong
Petz Aladar Megyei Oktato
ðŸ‡ðŸ‡ºGyor, Hungary
Adelaide and Meath National Childrens Hospital
🇮🇪Dublin, Ireland
Taipei Veterans General Hospital
🇨🇳Taipei, Taiwan
DEOEC Onkologiai Tanszek
ðŸ‡ðŸ‡ºDebrecen, Hungary
Beaumont Hospital
🇮🇪Dublin, Ireland
Mater Private Hospital
🇮🇪Dublin, Ireland
Hospital Nacional Carlos Alberto Seguin
🇵🇪Arequipa, Peru
IPO Francisco Gentil-Porto
🇵🇹Porto, Portugal
Institute of Oncology "AI.Trestioreanu"
🇷🇴Bucharest, Romania
Clinical Hospital Center Bezanijska Kosa
🇷🇸Belgrade, Serbia
Changhua Christian Hospital
🇨🇳Changhua, Taiwan
Chang Gung Memorial Hospital
🇨🇳Taoyuan, Taiwan
Kaposi Mor oktato korhaz Onkologiai tanszek
ðŸ‡ðŸ‡ºKaposvar, Hungary
Cork University Hospital
🇮🇪Cork, Ireland
Midwestern Regional Hospital
🇮🇪Limerick, Ireland
Sligo General Hospital
🇮🇪Sligo, Ireland
Sourasky (Ichilov) Medical Center
🇮🇱Tel Aviv, Israel
Assaf Harofeh Medical Center
🇮🇱Zerifin, Israel
P. Stradina Clinical University Hospital
🇱🇻Riga, Latvia
Centrum Onkologii Instytut im. M.
🇵🇱Gliwice, Poland
ZOZ MSWiA z Warminsko-Mazurskim Centrum
🇵🇱Olsztyn, Poland
Samodzielny Publiczny Zaklad Opieki
🇵🇱Rybnik, Poland
Institutul Oncologic "Prof. Dr. I. Chiricuta" Cluj-Napoca
🇷🇴Cluj-Napoca, Romania
Federal State Institution "Research Institute of Oncology n.a. N.N. Petrov Rosmedtechnologiy"
🇷🇺Saint Petersburg, Russian Federation
Institute for Cancer Research
🇮🇪Dublin, Ireland
Meir Medical Center
🇮🇱Kfar, Israel
Opcion Oncologia
🇲🇽Monterrey, Mexico
Cebu Doctors University Hospital
🇵ðŸ‡Cebu City, Philippines
Regional Oncology Center
🇵🇱Bialystok, Poland
Clinic of Oncology, Clinical Center nis
🇷🇸Nis, Serbia
State Institution "Russian Oncological Research Center n.a. N.N. Blokhin of RAMS"
🇷🇺Moscow, Russian Federation
Kaohsiung Medical University Chung
🇨🇳Kaohsiung, Taiwan
Hospital Nacional Edgardo Rebagliati Martins
🇵🇪Lima, Peru
Olsztynski Osrodek Onkologiczny "Kopernik"
🇵🇱Olsztyn, Poland
HUC
🇵🇹Coimbra, Portugal
County Hospital Alba-Iulia
🇷🇴Alba-Iulia, Romania
State Medical Institution "Republican Clinical Oncology Dispensary Ministry of Health of Republic Tatarstan"
🇷🇺Kazan, Russian Federation
Sun Yat-Sen Cancer Center
🇨🇳Taipei, Taiwan
Peterborough District Hospital
🇬🇧Peterborough, United Kingdom
Instituto Nacional de Cancer
🇧🇷Rio de Janeiro, RJ, Brazil
Clinica Oncologistas Associados
🇧🇷Rio de Janeiro, RJ, Brazil
Instituto de Oncologia Clinica de Piracicaba
🇧🇷Piracicaba, SP, Brazil
Ottawa Hospital Regional Cancer Centre
🇨🇦Ottawa, Ontario, Canada
Humber River Regional Hospital
🇨🇦Weston, Ontario, Canada
Windsor Regional Cancer Centre
🇨🇦Windsor, Ontario, Canada
Fundacion Jimenez Diaz
🇪🇸Madrid, Spain
Hospital Santa Maria Nai Dr. Cabaleiro
🇪🇸Ourense, Spain
Complejo Hospitalario de Pontevedra
🇪🇸Pontevedra, Spain
Hospital Universitario Virgen del Rocio
🇪🇸Sevilla, Spain
University of Colorado Cancer Center
🇺🇸Aurora, Colorado, United States
Florida Cancer Specialists
🇺🇸Tampa, Florida, United States
Carolyn Hendricks, MD
🇺🇸Bethesda, Maryland, United States
Suburban Hospital
🇺🇸Bethesda, Maryland, United States
Oncology Alliance-South
🇺🇸Milwaukee, Wisconsin, United States
Klinikum Schaumburg
🇩🇪Stadhagen, Germany
Hochwaldkrankenhaus
🇩🇪Bad Nauheim, Germany
University Hospital and Medical Center-SUNY
🇺🇸Stony Brook, New York, United States
University Hospital and Medical Center - SUNY
🇺🇸Stony Brook, New York, United States
Park Nicollet Health Services
🇺🇸Saint Louis Park, Minnesota, United States
Hubert H. Humphrey Cancer Center - Fridley
🇺🇸Fridley, Minnesota, United States
Minnesota Hematology Oncology-St. Paul
🇺🇸Saint Paul, Minnesota, United States
Minnesota Oncology Hematology
🇺🇸Woodbury, Minnesota, United States
Shaw Regional Cancer Center
🇺🇸Edwards, Colorado, United States
CCOP, Wayne Memorial Hospital
🇺🇸Goldsboro, North Carolina, United States
Moses Cone Regional Cancer Center
🇺🇸Greensboro, North Carolina, United States
Northwestern Carolina Oncology & Hematology, PA
🇺🇸Hickory, North Carolina, United States
Carolina BioOncology Institute
🇺🇸Huntersville, North Carolina, United States
Florida Cancer Specialists-Englewood
🇺🇸Englewood, Florida, United States
Florida Cancer Specialists-Bradenton
🇺🇸Bradenton, Florida, United States
Oncology, P.C. Plymouth
🇺🇸Plymouth, Indiana, United States
Spectrum Health Hospitals
🇺🇸Grand Rapids, Michigan, United States
UP Hematology/Oncology Associates-Gogebic Range
🇺🇸Ironwood, Michigan, United States
Hematology Oncology-Lapeer
🇺🇸Lapeer, Michigan, United States
Michigan State University - Breslin Cancer Center
🇺🇸Lansing, Michigan, United States
Marquette General Hospital
🇺🇸Marquette, Michigan, United States
Community Cancer Care Specialists-Mt. Clemens
🇺🇸Mount Clemens, Michigan, United States
Upper Peninsula Hematology/Oncology Associates
🇺🇸Marquette, Michigan, United States
Hackley Hospital
🇺🇸Muskegon, Michigan, United States
CCOP, William Beaumont Hospital
🇺🇸Royal Oak, Michigan, United States
Michiana Hematology-Oncology, PC Lakeland
🇺🇸Saint Joseph, Michigan, United States
Chippewa Medical Associates
🇺🇸Sault Sainte-Marie, Michigan, United States
Osteopathic Medical Oncology Hematology
🇺🇸Shelby, Michigan, United States
Munson Medical Center
🇺🇸Traverse City, Michigan, United States
CCOP, St. John Macomb Hospital
🇺🇸Warren, Michigan, United States
Sutter Medical Center
🇺🇸Sacramento, California, United States
Sutter Medical Group
🇺🇸Sacramento, California, United States
CCOP, St. Joseph Mercy Hospital
🇺🇸Ann Arbor, Michigan, United States
Michiana Hematology-Oncology, P.C. (LaPorte)
🇺🇸LaPorte, Indiana, United States
Hematology and Medical Oncology Consultants-Davenport
🇺🇸Davenport, Iowa, United States
Hospital Clinico Universitario de Valencia
🇪🇸Valencia, Spain
Suburban Hematology Oncology Associates PC
🇺🇸Snellville, Georgia, United States
Palm Beach Cancer Institute
🇺🇸West Palm Beach, Florida, United States
Central Georgia Cancer Care
🇺🇸Macon, Georgia, United States
MBCCOP, John H. Stroger, JR., Hospital of Cook County-Chicago
🇺🇸Chicago, Illinois, United States
Hematology/Oncology Associates of OH and MI, PC
🇺🇸Lambertville, Michigan, United States
Tri County Hematology/Oncology
🇺🇸Canton, Ohio, United States
UHHS Westlake-Ireland Cancer Center
🇺🇸Westlake, Ohio, United States
Marian A. Llenado Lee, MD, Inc.
🇺🇸Kettering, Ohio, United States
Mount Clemens Regional Medical Center
🇺🇸Mount Clemens, Michigan, United States
Battle Creek Health System
🇺🇸Battle Creek, Michigan, United States
Hematology and Medical Oncology Consultants-Bettendorf
🇺🇸Bettendorf, Iowa, United States
Case Western Reserve/University Hospitals-Ireland Cancer Cntr.
🇺🇸Cleveland, Ohio, United States
Dayton Clinical Oncology Program-Kettering
🇺🇸Kettering, Ohio, United States
Mount Nittany Medical Center
🇺🇸State College, Pennsylvania, United States
Oncology Alliance-Franklin
🇺🇸Franklin, Wisconsin, United States
Althaia Xarxa Assistencial de Manresa
🇪🇸Barcelona, Spain
Hospital Espiritu Santo
🇪🇸Barcelona, Spain
UPMC Cancer Centers - UPMC Passavant
🇺🇸Pittsburgh, Pennsylvania, United States
Florida Hospital Cancer Institute
🇺🇸Orlando, Florida, United States
NortonHealthcare Pavillion
🇺🇸Louisville, Kentucky, United States
Norton Medical Plaza II
🇺🇸Louisville, Kentucky, United States
Norton Medical Plaza West
🇺🇸Louisville, Kentucky, United States
Old Brownsboro Crossing
🇺🇸Louisville, Kentucky, United States
Saint Luke's Hospital
🇺🇸Kansas City, Missouri, United States
CCOP, Kansas City (Administrative Only)
🇺🇸Kansas City, Missouri, United States
Robert R. Carroll, MD, PA
🇺🇸Gainesville, Florida, United States
Oncare Hawaii, Inc-POB2
🇺🇸Honolulu, Hawaii, United States
Straub Clinic and Hospital
🇺🇸Honolulu, Hawaii, United States
University of Hawaii
🇺🇸Honolulu, Hawaii, United States
Oncare Hawaii, Inc-KMP
🇺🇸Honolulu, Hawaii, United States
VCU Massey Cancer Center at Stony Point
🇺🇸Richmond, Virginia, United States
MBCCOP, Virginia Commonwealth University
🇺🇸Richmond, Virginia, United States
University of Kentucky Medical Center
🇺🇸Lexington, Kentucky, United States
Dayton Physicians-LLC-Hematology & Medical Oncology Division
🇺🇸Dayton, Ohio, United States
Cross Cancer Institute, Dept of Medicine
🇨🇦Edmonton, Alberta, Canada
Carolinas Medical Center - Blumenthal Cancer Center
🇺🇸Charlotte, North Carolina, United States
Northern Arizona Hematology & Oncology Associates
🇺🇸Sedona, Arizona, United States
Michiana Hematology-Oncology PC
🇺🇸Niles, Michigan, United States
Dr. Cook and Abramson - Bay City
🇺🇸Bay City, Michigan, United States
Integrated Community Oncology Network
🇺🇸Orange Park, Florida, United States
UP Hematology/Oncology Associates
🇺🇸Iron Mountain, Michigan, United States
Breastlink Medical Group, Inc
🇺🇸Hawthorne, California, United States
Prince of Wales Hospital
ðŸ‡ðŸ‡°Hong Kong, Hong Kong